26.6 C
Australia
Friday, October 23, 2020

Guidelines detail management of liver failure in ICU patients

Must read

NSW Premier Gladys Berejiklian’s relationship could get her in trouble, experts say

The NSW Premier could be in “real trouble” if claims she was cohabitating with her secret ex-lover were proven true, experts have said.In...

Household calls for solutions after allegedly sexually abused woman takes her personal life

The household of a woman, who took her personal life after her alleged intercourse abuser was granted bail, have thrown their “full blown...
The Indian Telegraphhttps://theindiantelegraph.com.au/
Established in 2007, The Indian Telegraph is a multi award winning digital media company based in Australia.

(HealthDay)—In an executive summary of a new guideline from the Society of Critical Care Medicine, published in the March issue of Critical Care Medicine, a set of evidence-based recommendations are presented for the management of liver failure in critically ill patients.

Rahul Nanchal, M.D., from the Medical College of Wisconsin in Milwaukee, and colleagues developed 29 recommendations on management of acute liver failure (ALF) or acute-on-chronic liver failure (ACLF) in the intensive care unit, with cardiovascular, hematology, pulmonary, renal, and endocrine considerations.

Six of the recommendations were strong. For initial fluid resuscitation of patients with ALF or ACLF, the authors recommend against use of hydroxyethyl starch. Gelatin solutions are not suggested for initial fluid resuscitation, while albumin is suggested over other fluids. For patients who remain hypotensive despite fluid resuscitation or those with profound hypotension and tissue hypoperfusion even if fluid resuscitation is ongoing, norepinephrine is recommended as a first-line vasopressor. In critically ill patients undergoing procedures, viscoelastic testing is recommended over measuring the international normalized ratio, platelet, and fibrinogen. In ACLF patients with thrombocytopenia prior to surgery/invasive procedures, Eltrombopag is not recommended. Vasopressors are recommended in critically ill patients with ACLF who develop hepatorenal syndrome. A serum blood glucose of 110 to 180 mg/dL should be targeted in patients with ALF or ACLF.

“These guidelines are meant to supplement and not replace an individual clinician’s cognitive decision making,” the authors write.

One author disclosed serving as an expert witness regarding the treatment of hepatitis C virus infection.

Latest article

Denise Jane Lee: Judge overturns doctor’s ‘tone deaf’ jail sentence

A former Sydney doctor’s jail term for harassing the partner of an ex-Tinder flame has been overturned as a judge took aim at...

NRL and AFL grand finals weather: What to expect this weekend

Wild weather is due to hit the eastern half of Australia on Friday, dumping a lot of rain and strong winds on parts...

Thule stroller recall over fears it could injure children

A stroller has been recalled over fears a defect could cause risk of injury to children. The Australian Competition and Consumer Commission issued...

Baby formula: Police seize 1350 tins in Sydney, charge two

Police have seized 1350 tins of baby formula and other pharmaceutical items and charged two men with stealing it from stores to send...

NSW Premier Gladys Berejiklian’s relationship could get her in trouble, experts say

The NSW Premier could be in “real trouble” if claims she was cohabitating with her secret ex-lover were proven true, experts have said.In...